# Bristol-Myers Squibb Company  Share Price Target ‘$52.16’, now 26.8% Upside Potential

- Link: https://www.directorstalkinterviews.com/bristol-myers-squibb-company-share-price-target-52.16-now-26.8-upside-potential/4121164745
- Published: 2024-07-12T15:07:06+01:00
- Author: Charlotte Edwards

**Bristol-Myers Squibb Company** with ticker code (BMY) have now 21 confirmed analysts
covering the stock with the consensus suggesting a rating of ‘hold’. The range between
the high target price and low target price is between $75.00 and $37.00 with the
average share target price sitting at $52.16. (at the time of writing). Given that
the stocks previous close was at $41.12 this would indicate that there is a potential
upside of 26.8%. The day 50 moving average is $42.18 and the 200 moving average 
now moves to $49.25. The company has a market cap of 82.60B. The stock price for
the company is currently $40.75 USD

 The potential market cap would be $104,782,142,309 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of -, revenue per share of $22.21 and
a 5.39% return on assets.

Bristol-Myers Squibb Company is a biopharmaceutical company. The Company is engaged
in the discovery, development, licensing, manufacturing, marketing, distribution,
and sale of biopharmaceutical products. It offers products for a range of therapeutic
classes, which include oncology, immunology, cardiovascular and hematology. Its 
pharmaceutical products include chemically synthesized or small molecule drugs and
products produced from biological processes, called biologics. Biologics are administered
to patients through injections or by infusion. Its products include Revlimid, Abecma,
Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Sprycel, Yervoy, Abraxane, Empliciti,
Reblozyl, Inrebic, Onureg, Zeposia, Camzyos, and Breyanzi. It also has a pipeline
of investigational medicines designed to target the common mutations associated 
with oncogenesis, including repotrectinib. Its products are sold to wholesalers,
distributors, pharmacies, retailers, hospitals, clinics, and government agencies.

Share on: